Differentiating odontogenic myxoma from ameloblastoma by focusing on cyst-like areas on MR images
- PMID: 40668502
- DOI: 10.1007/s11282-025-00841-2
Differentiating odontogenic myxoma from ameloblastoma by focusing on cyst-like areas on MR images
Abstract
Objectives: This study aimed to identify characteristic findings of odontogenic myxoma (OM) and assess the role of MRI in differentiating OM from ameloblastoma by analysing cyst-like areas.
Methods: MRI images from 12 and 15 patients with OM and ameloblastoma, respectively, were retrospectively evaluated to determine imaging features useful for differentiation. We analysed cyst-like areas in OM using apparent diffusion coefficient (ADC) values and gadolinium contrast patterns, comparing them with those in ameloblastoma. ADC values were statistically assessed via the Mann-Whitney U test.
Results: In OM, the mean ADC value of cyst-like areas was 1.84 × 10⁻3 mm2/s. Contrast-enhanced T1-weighted images showed signal enhancement, with a gradual increase on dynamic contrast-enhanced MRI (DCE-MRI). Conversely, in ameloblastoma, the mean ADC value was 2.28 × 10⁻3 mm2/s. Unlike OM, its cyst-like areas lacked enhancement, with only the solid areas exhibiting a rapid signal increase on DCE-MRI. ADC values were significantly higher in ameloblastoma (P < 0.05).
Conclusions: The presence or absence of contrast enhancement in cyst-like areas aids in differentiating OM from ameloblastoma. Additionally, ADC values may be used to differentiate between these tumors in the absence of contrast agents.
Keywords: Ameloblastoma; Diffusion-weighted MR imaging; MRI; Odontogenic myxoma.
© 2025. The Author(s) under exclusive licence to Japanese Society for Oral and Maxillofacial Radiology.
Conflict of interest statement
Declarations. Conflicts of interest: None of the authors have any conflicts of interest to declare with respect to this study. Ethics approval: The study protocol was approved by our Institutional Review Board (D2020-066). Informed consent: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. The requirement for informed consent was waived owing to the retrospective nature of the study.
Similar articles
-
Characterizing Breast Tumor Heterogeneity Through IVIM-DWI Parameters and Signal Decay Analysis.Diagnostics (Basel). 2025 Jun 12;15(12):1499. doi: 10.3390/diagnostics15121499. Diagnostics (Basel). 2025. PMID: 40564820 Free PMC article.
-
Diagnostic Utility of Diffusion-Weighted MRI and Apparent Diffusion Coefficient Values in Differentiating Metastatic From Non-metastatic Lymph Nodes in Cervical Carcinoma.Cureus. 2025 Jun 4;17(6):e85371. doi: 10.7759/cureus.85371. eCollection 2025 Jun. Cureus. 2025. PMID: 40621327 Free PMC article.
-
Diffusion-weighted magnetic resonance imaging for differentiation of unicystic ameloblastoma, odontogenic keratocyst, and dentigerous cyst: A systematic review and network meta-analysis.Imaging Sci Dent. 2025 Jun;55(2):105-113. doi: 10.5624/isd.20240227. Epub 2025 Apr 28. Imaging Sci Dent. 2025. PMID: 40607070 Free PMC article. Review.
-
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2. Cochrane Database Syst Rev. 2018. PMID: 29357120 Free PMC article.
-
The Role of Dynamic Contrast Enhanced Magnetic Resonance Imaging in Evaluating Prostate Adenocarcinoma: A Partially-Blinded Retrospective Study of a Prostatectomy Patient Cohort With Whole Gland Histopathology Correlation and Application of PI-RADS or TNM Staging.Prostate. 2025 Apr;85(5):413-423. doi: 10.1002/pros.24843. Epub 2024 Dec 19. Prostate. 2025. PMID: 39702937 Free PMC article.
References
-
- El-Naggar AK, Grandis JR, Takata T, Slootweg PJ, editors. WHO classification of head and neck tumours. 4th ed. Lyon: International Agency for Research on Cancer Publications; 2017.
-
- Chrcanovic BR, Gomez RS. Odontogenic myxoma: an updated analysis of 1,692 cases reported in the literature. Oral Dis. 2019;25:676–83. https://doi.org/10.1111/odi.12875 . - DOI - PubMed
-
- Saalim M, Sansare K, Karjodkar FR, Farman AG, Goyal SN, Sharma SR. Recurrence rate of odontogenic myxoma after different treatments: a systematic review. Br J Oral Maxillofac Surg. 2019;57:985–91. https://doi.org/10.1016/j.bjoms.2019.09.005 . - DOI - PubMed
-
- Takahashi Y, Tanaka K, Hirai H, Marukawa E, Izumo T, Harada H. Appropriate surgical margin for odontogenic myxoma: a review of 12 cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;126:404–8. https://doi.org/10.1016/j.oooo.2018.06.002 . - DOI - PubMed
-
- Sumi Y, Miyaishi O, Ito K, Ueda M. Magnetic resonance imaging of myxoma in the mandible: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90:671–6. https://doi.org/10.1067/moe.2000.108917 . - DOI - PubMed